Monday - March 17, 2025
Ropes & Gray Represents Abilita Therapeutics in Orion Research Collaboration to Develop Next-Generation Antibody Therapeutics
December 21, 2024
BOSTON, Massachusetts, Dec. 21 -- Ropes and Gray, a law firm, issued the following news:

Ropes & Gray advised Abilita Therapeutics in a global licensing and multi-target research collaboration with Finnish Orion Corporation (Orion) focused on discovery, development and commercialization of next-generation antibody therapeutics in oncology and pain.

The companies will use Abilita's pioneering antibody discovery platform to unlock challenging multi-span membrane . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products